InsiderClue
← All stocks

Nuvation Bio Inc.

NUVB Mostly scheduled
CIK 0001811063 #1916 in the set updated 18 Sep 2026
Bought (12 mo)
$118.25K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$9.68M
$0.00 on a plan · $9.68M straight out of an exercise
Sold at will
$0.00
0 of 17 sales
Net
−$9.56M
+$118.25K against sales at will

By person

11 insiders · 20 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Hattersley Gary
CHIEF SCIENTIFIC OFFICER
—
$3.88M (4) scheduled
−$3.88M
0
0.0000%
$0.00
—
Liu Dongfang
CHIEF MEDICAL OFFICER
—
$1.87M (7) scheduled
−$1.87M
18,000
0.0051%
$127.66K
0.0%
Wentworth Kerry
CHIEF REGULATORY OFFICER
—
$1.47M (3) scheduled
−$1.47M
53,000
0.0151%
$375.90K
+1,667%
Hanley David C.
CHIEF TECHNICAL OPERATIONS
—
$1.43M (1) scheduled
−$1.43M
24,000
0.0068%
$170.22K
0.0%
Markel Stacy
CHIEF PEOPLE OFFICER
—
$753.19K (1) scheduled
−$753.19K
32,591
0.0093%
$231.15K
+44.3%
Sauvage Philippe
Chief Financial Officer
—
$286.37K (1) scheduled
−$286.37K
54,131
0.0154%
$383.92K
+692.4%
Mashal Robert
Director
$118.25K (1)
—
+$118.25K
225,000
0.0641%
$1.60M
—
Hung David
PRESIDENT AND CEO
—
—
—
59,281,054
16.88%
$420.44M
+1.7%
Wang Junyuan Jerry
CEO, ANHEART THERAPEUTICS LTD.
—
—
—
3,866,228
1.10%
$27.42M
−1.4%
Sjogren Colleen
Chief Commercial Officer
—
—
—
81,000
0.0231%
$574.48K
+161.3%
Makunje Moses
SEE REMARKS
—
—
—
68,137
0.0194%
$483.25K
+292.1%

Individual transactions

20
Insider
Date
Role
Action
Shares
Price
Amount
Hattersley Gary
19 Aug 2026
CHIEF SCIENTIFIC OFFICER
Sold after exercise
100,000
$7.09
$709.24K
Sauvage Philippe
15 Jul 2026
Chief Financial Officer
Exercised, kept
1
$1.97
$1.97
Sauvage Philippe
15 Jul 2026
Chief Financial Officer
Exercised, kept
39,999
$2.17
$86.80K
Sauvage Philippe
23 Jun 2026
Chief Financial Officer
Sold after exercise
47,668
$6.01
$286.37K
Wentworth Kerry
23 Jun 2026
CHIEF REGULATORY OFFICER
Sold after exercise
63,000
$6.02
$379.19K
Markel Stacy
23 Jun 2026
CHIEF PEOPLE OFFICER
Sold after exercise
125,000
$6.03
$753.19K
Mashal Robert
9 Jun 2026
Director
Buy indirect
25,000
$4.73
$118.25K
Liu Dongfang
17 Apr 2026
CHIEF MEDICAL OFFICER
Sold after exercise
50,000
$5.02
$251.00K
Wentworth Kerry
17 Apr 2026
CHIEF REGULATORY OFFICER
Sold after exercise
36,750
$5.01
$184.28K
Wentworth Kerry
6 Apr 2026
CHIEF REGULATORY OFFICER
Sold after exercise
200,000
$4.52
$903.56K
Liu Dongfang
1 Dec 2025
CHIEF MEDICAL OFFICER
Sold after exercise
150,000
$7.82
$1.17M
Liu Dongfang
26 Nov 2025
CHIEF MEDICAL OFFICER
Sold after exercise
10,000
$8.00
$80.00K
Liu Dongfang
25 Nov 2025
CHIEF MEDICAL OFFICER
Sold after exercise
10,000
$7.50
$75.00K
Liu Dongfang
20 Nov 2025
CHIEF MEDICAL OFFICER
Sold after exercise
20,000
$7.00
$140.07K
Hattersley Gary
20 Nov 2025
CHIEF SCIENTIFIC OFFICER
Sold after exercise
300,000
$7.23
$2.17M
Hattersley Gary
20 Nov 2025
CHIEF SCIENTIFIC OFFICER
Sold after exercise
69,051
$7.23
$499.03K
Liu Dongfang
19 Nov 2025
CHIEF MEDICAL OFFICER
Sold after exercise
15,000
$5.10
$76.55K
Hanley David C.
19 Nov 2025
CHIEF TECHNICAL OPERATIONS
Sold after exercise
200,000
$7.14
$1.43M
Liu Dongfang
17 Nov 2025
CHIEF MEDICAL OFFICER
Sold after exercise
15,000
$4.77
$71.48K
Hattersley Gary
27 Oct 2025
CHIEF SCIENTIFIC OFFICER
Sold after exercise
100,000
$5.02
$502.46K

What was left out

Form 4 filings counted 32
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 17
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,602,230
History held since 6 Jul 2020